Engineered heart tissue model of diabetic myocardium.

Myocardial infarction resulting in irreversible loss of cardiomyocytes (CMs) is a leading cause of heart failure. Previously, we reported an in vitro test-bed for screening cell integration between injected test cells and host CM using the engineered heart tissue as a recipient. The objective of this study is to expand our system to diabetic cardiomyopathy conditions. Patients with diabetes show dysfunction of CMs independent of myocardial infarction, indicating that diabetes directly affects CMs. However, the underlying mechanisms are not fully understood, and developing a diabetic CM test-bed could enable drug screening studies specific to the diabetic heart. Diabetic cardiac conditions were mimicked by cultivating neonatal rat CMs seeded onto collagen scaffolds in normal or high glucose with or without insulin. Our results show that high glucose conditions, which mimic diabetic hearts, display poor electrical properties. Gene expression profiles from diabetic, adult, and neonatal rat hearts as well as engineered heart tissues under different conditions were compared. The diabetic rat heart and high glucose conditions increased the ratio of myosin heavy-chain isoform β to α indicative of diseased states; thus, this model system captures some molecular aspects of diabetic cardiomyopathy. Moreover, thiazolidinedione diabetic drug treatment improved electrical excitabilities and exhibited anti-apoptotic effects.

[1]  R. Hajjar,et al.  Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy , 2008, Nature Clinical Practice Cardiovascular Medicine.

[2]  Milica Radisic,et al.  Medium perfusion enables engineering of compact and contractile cardiac tissue. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  T. Yipintsoi,et al.  The Effect of Diabetes on Performance and Metabolism of Rat Hearts , 1980, Circulation research.

[4]  S. Chakrabarti,et al.  miR133a regulates cardiomyocyte hypertrophy in diabetes , 2010, Diabetes/metabolism research and reviews.

[5]  S. Bastacky,et al.  RENAL FUNCTION AND STRUCTURE IN DIABETIC, HYPERTENSIVE, OBESE ZDFxSHHF-HYBRID RATS , 2000, Renal failure.

[6]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[7]  P. Anversa,et al.  IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. , 2001, Diabetes.

[8]  S. Verma,et al.  Preservation of heart function in diabetic rats by the combined effects of muscle cell implantation and insulin therapy , 2008, European journal of heart failure.

[9]  J. Ingwall,et al.  Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency. , 2007, Journal of molecular and cellular cardiology.

[10]  P. Razeghi,et al.  Return to the fetal gene program protects the stressed heart: a strong hypothesis , 2007, Heart Failure Reviews.

[11]  P. Kang,et al.  Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Manuel J. Aybar,et al.  Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats. , 2001, Journal of ethnopharmacology.

[14]  J. Lin,et al.  Comparative studies on the expression patterns of three troponin T genes during mouse development , 2001, The Anatomical record.

[15]  J. Robbins,et al.  Impact of beta-myosin heavy chain expression on cardiac function during stress. , 2004, Journal of the American College of Cardiology.

[16]  A. Baraka,et al.  Targeting Apoptosis in the Heart of Streptozotocin-Induced Diabetic Rats , 2010, Journal of cardiovascular pharmacology and therapeutics.

[17]  T. Hewett,et al.  Analysis of Myosin Heavy Chain Functionality in the Heart* , 2003, The Journal of Biological Chemistry.

[18]  Kumaraswamy Nanthakumar,et al.  Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment , 2011, Biotechnology and bioengineering.

[19]  Kumar V. S. Nemmani,et al.  Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents , 2010, Expert opinion on investigational drugs.

[20]  Milica Radisic,et al.  Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. , 2007, Biomaterials.

[21]  Milica Radisic,et al.  Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. , 2011, Tissue engineering. Part A.

[22]  T. Horio,et al.  Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. , 2000, Hypertension.

[23]  M. Radisic,et al.  Pulsatile perfusion bioreactor for cardiac tissue engineering , 2008, Biotechnology progress.

[24]  Masayuki Yamato,et al.  Endothelial Cell Coculture Within Tissue-Engineered Cardiomyocyte Sheets Enhances Neovascularization and Improves Cardiac Function of Ischemic Hearts , 2008, Circulation.

[25]  N. Bishopric,et al.  Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[26]  N. Norton,et al.  Coding Sequence Rare Variants Identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 From 312 Patients With Familial or Idiopathic Dilated Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.

[27]  Mu Wang,et al.  Carbonylation of myosin heavy chains in rat heart during diabetes. , 2010, Biochemical pharmacology.

[28]  I. Poornima,et al.  Diabetic cardiomyopathy: the search for a unifying hypothesis. , 2006, Circulation research.

[29]  D. Lefer,et al.  Myocardial infarction and heart failure in the db/db diabetic mouse. , 2006, American journal of physiology. Heart and circulatory physiology.

[30]  P. Li,et al.  In Cardiomyocyte Hypoxia, Insulin-Like Growth Factor-I-Induced Antiapoptotic Signaling Requires Phosphatidylinositol-3-OH-Kinase-Dependent and Mitogen-Activated Protein Kinase-Dependent Activation of the Transcription Factor cAMP Response Element-Binding Protein , 2001, Circulation.

[31]  A. Nygren,et al.  Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve , 2007, The Journal of physiology.

[32]  P. Kang,et al.  The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway* , 2004, Journal of Biological Chemistry.

[33]  R Langer,et al.  Biomimetic approach to cardiac tissue engineering , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[34]  T. Hewett,et al.  Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. , 2000, American journal of physiology. Heart and circulatory physiology.

[35]  S. Bastacky,et al.  RENAL AND METABOLIC EFFECTS OF CAFFEINE IN OBESE (fa/facp), DIABETIC, HYPERTENSIVE ZSF1 RATS* , 2001, Renal failure.

[36]  E. Ashley,et al.  Chromatin regulation by Brg1 underlies heart muscle development and disease , 2010, Nature.

[37]  L. Leinwand,et al.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. , 1989, Journal of molecular biology.

[38]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[39]  J. Halter,et al.  Insulin secretion in diabetes mellitus. , 1981, The American journal of medicine.

[40]  S. Rosenkranz,et al.  PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. , 2010, Journal of molecular and cellular cardiology.

[41]  Kumaraswamy Nanthakumar,et al.  Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue , 2009, Proceedings of the National Academy of Sciences.

[42]  A. Luchner,et al.  Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.